Quarterly report pursuant to Section 13 or 15(d)

Document and Entity Information

v3.10.0.1
Document and Entity Information - shares
6 Months Ended
Sep. 30, 2018
Oct. 26, 2018
Document And Entity Information    
Entity Registrant Name VistaGen Therapeutics, Inc.  
Entity Central Index Key 0001411685  
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Non-accelerated Filer  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Common Stock, Shares Outstanding   31,057,215
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2019